The University of Chicago Header Logo

Connection

Anand Patel to Myelodysplastic Syndromes

This is a "connection" page, showing publications Anand Patel has written about Myelodysplastic Syndromes.
Connection Strength

2.052
  1. Treatment of Anemia in Lower-Risk Myelodysplastic Syndrome. Curr Treat Options Oncol. 2024 Jun; 25(6):752-768.
    View in: PubMed
    Score: 0.733
  2. Novel Therapies in Myelodysplastic Syndrome: Where Do Venetoclax and Isocitrate Dehydrogenase Inhibitors Fit in? Cancer J. 2023 May-Jun 01; 29(3):188-194.
    View in: PubMed
    Score: 0.680
  3. Cedazuridine/decitabine: from preclinical to clinical development in myeloid malignancies. Blood Adv. 2021 04 27; 5(8):2264-2271.
    View in: PubMed
    Score: 0.592
  4. Prognostic impact of 'multi-hit' versus 'single-hit' TP53 alteration in patients with acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases. Haematologica. 2024 11 01; 109(11):3533-3542.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.